Nomacopan

N/A

Report date: 2026/02/03 20:00:14

Base Information

Drug NameNomacopan
Drug Alias NamePAS-coversinPAS-nomacopanlong-acting PAS-nomacopanCoversinrEV-576 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement C5 inhibitorsLeukotriene B4 inhibitors
TargetsComplement C5Leukotriene B4
Therapy Area/IndicationsPemphigoid, BullousThrombotic MicroangiopathiesHemoglobinuria, Paroxysmal +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandNetherlands +[9] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvolutec
China Registration ClassN/A

Develop Information

Active CompaniesPeak Bio Inc
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsPemphigoid, BullousThrombotic MicroangiopathiesHemoglobinuria, Paroxysmal +[4] 

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG